Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome

被引:36
作者
Zegri-Reiriz, Isabel [1 ]
Javier de Haro-del Moral, F. [2 ]
Dominguez, Fernando [1 ,3 ,4 ]
Salas, Clara [3 ,5 ]
de la Cuadra, Pablo [6 ]
Plaza, Aresio [7 ]
Krsnik, Isabel [8 ]
Gonzalez-Lopez, Esther [1 ,3 ,4 ]
Garcia-Pavia, Pablo [1 ,3 ,9 ]
机构
[1] Hosp Univ Puerta Hierro, Dept Cardiol, Manuel Falla 2, Madrid 28222, Spain
[2] Hosp Univ Puerta Hierro, Dept Nucl Med, Madrid, Spain
[3] CIBER Cardiovasc Dis CIBERCV, Madrid, Spain
[4] CNIC, Myocardial Biol Programme, Madrid, Spain
[5] Hosp Univ Puerta Hierro, Dept Pathol, Madrid, Spain
[6] Hosp Univ Puerta Hierro, Dept Orthopaed & Traumatol, Madrid, Spain
[7] Hosp Univ Puerta Hierro, Dept Immunol, Madrid, Spain
[8] Hosp Univ Puerta Hierro, Dept Hematol, Madrid, Spain
[9] UFV, Madrid, Spain
关键词
Amyloidosis; Tansthyretin; Carpal tunnel syndrome; TRANSTHYRETIN; DIAGNOSIS;
D O I
10.1007/s12265-019-09895-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carpal tunnel syndrome (CTS) is a common finding among patients with cardiac amyloidosis. We sought to determine the prevalence of cardiac amyloidosis in patients who had undergone CTS surgery. From 2005 to 2014, 308 patients >= 60 years underwent CTS surgery. Of these, 233 (76%) agreed to participate in the study and 101 (73 +/- 8 years; 68% females) showed left ventricular hypertrophy (LVH) >= 12 mm and underwent additional studies to diagnose AL and ATTR amyloidosis. Based on complementary studies, three patients were diagnosed with cardiac amyloidosis (two wild-type ATTR and one AL). The three patients showed bilateral CTS with no occupational risk factors. Prevalence of cardiac amyloidosis in the overall cohort was only 1.2% (3/233), but among patients with LVH and bilateral CTS, the prevalence was 5.5% (3/55) and 13.6% (3/22) if cases with an occupational risk factor were excluded. Cardiac amyloidosis should be excluded in the presence of bilateral CTS and particularly if an occupational risk factor is absent.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 15 条
[1]   Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy [J].
Ackermann, Elizabeth J. ;
Guo, Shuling ;
Booten, Sheri ;
Alvarado, Luis ;
Benson, Merrill ;
Hughes, Steve ;
Monia, Brett P. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 :43-44
[2]   Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial [J].
Coelho, Teresa ;
Maia, Luis F. ;
da Silva, Ana Martins ;
Cruz, Marcia Waddington ;
Plante-Bordeneuve, Violaine ;
Lozeron, Pierre ;
Suhr, Ole B. ;
Campistol, Josep M. ;
Conceicao, Isabel Maria ;
Schmidt, Hartmut H. -J. ;
Trigo, Pedro ;
Kelly, Jeffery W. ;
Labaudinie, Richard ;
Chan, Jason ;
Packman, Jeff ;
Wilson, Amy ;
Grogan, Donna R. .
NEUROLOGY, 2012, 79 (08) :785-792
[3]   Cardiac amyloidosis : An update on diagnosis and treatment [J].
Donnelly, Joseph P. ;
Hanna, Mazen .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 :12-26
[4]   Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis [J].
Geller, Hallie I. ;
Singh, Avinainder ;
Alexander, Kevin M. ;
Mirto, Tara M. ;
Falk, Rodney H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (10) :962-963
[5]   Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis [J].
Gillmore, Julian D. ;
Maurer, Mathew S. ;
Falk, Rodney H. ;
Merlini, Giampaolo ;
Damy, Thibaud ;
Dispenzieri, Angela ;
Wechalekar, Ashutosh D. ;
Berk, John L. ;
Quarta, Candida C. ;
Grogan, Martha ;
Lachmann, Helen J. ;
Bokhari, Sabahat ;
Castano, Adam ;
Dorbala, Sharmila ;
Johnson, Geoff B. ;
Glaudemans, Andor W. J. M. ;
Rezk, Tamer ;
Fontana, Marianna ;
Palladini, Giovanni ;
Milani, Paolo ;
Guidalotti, Pierluigi L. ;
Flatman, Katarina ;
Lane, Thirusha ;
Vonberg, Frederick W. ;
Whelan, Carol J. ;
Moon, James C. ;
Ruberg, Frederick L. ;
Miller, Edward J. ;
Hutt, David F. ;
Hazenberg, Bouke P. ;
Rapezzi, Claudio ;
Hawkins, Philip N. .
CIRCULATION, 2016, 133 (24) :2404-+
[6]  
González-López E, 2017, REV ESP CARDIOL, V70, P991, DOI [10.1016/j.rec.2017.05.036, 10.1016/j.recesp.2017.05.018]
[7]   Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disprovingmyths [J].
Gonzalez-Lopez, Esther ;
Gagliardi, Christian ;
Dominguez, Fernando ;
Quarta, Cristina Candida ;
Javier de Haro-del Moral, F. ;
Milandri, Agnese ;
Salas, Clara ;
Cinelli, Mario ;
Cobo-Marcos, Marta ;
Lorenzini, Massimiliano ;
Lara-Pezzi, Enrique ;
Foffi, Serena ;
Alonso-Pulpon, Luis ;
Rapezzi, Claudio ;
Garcia-Pavia, Pablo .
EUROPEAN HEART JOURNAL, 2017, 38 (24) :1895-1904
[8]   Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction [J].
Gonzalez-Lopez, Esther ;
Gallego-Delgado, Maria ;
Guzzo-Merello, Gonzalo ;
de Haro-del Moral, F. Javier ;
Cobo-Marcos, Marta ;
Robles, Carolina ;
Bornstein, Belen ;
Salas, Clara ;
Lara-Pezzi, Enrique ;
Alonso-Pulpon, Luis ;
Garcia-Pavia, Pablo .
EUROPEAN HEART JOURNAL, 2015, 36 (38) :2585-2594
[9]  
de Haro-del Moral F, 2012, REV ESP CARDIOL, V65, P440, DOI [10.1016/j.rec.2011.12.016, 10.1016/j.recesp.2011.12.015]
[10]   Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium [J].
Lousada, Isabelle ;
Comenzo, Raymond L. ;
Landau, Heather ;
Guthrie, Spencer ;
Merlini, Giampaolo .
ADVANCES IN THERAPY, 2015, 32 (10) :920-928